Status:
UNKNOWN
Randomized Clinical Trial of Phonological Interventions
Lead Sponsor:
McGill University
Conditions:
Speech Articulation Disorder
Developmental Articulation Disorder
Eligibility:
All Genders
48-71 years
Phase:
PHASE2
PHASE3
Brief Summary
Recent research reveals genetic and symptomatic overlap among children with speech sound disorders (i.e., those who (misarticulate more sounds than would be expected for their age) and children with d...
Detailed Description
The 72 children participating in the study will be randomly assigned (with concealment of the randomization sequence from study staff) to one of two Child Speech Interventions: Speech Perception or Sp...
Eligibility Criteria
Inclusion
- primary diagnosis of speech articulation disorder/phonological impairment
- age 4 to 5 years of age at onset of treatment
- maternal language Canadian French (at least 75% exposure)
- must misarticulate at least two phonemes that would typically be mastered by their normally developing age peers
Exclusion
- speech disorder is secondary to a primary condition (e.g., hearing impairment, cleft palate, autism, Down syndrome etc.)
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2010
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT00818428
Start Date
November 1 2008
End Date
July 1 2010
Last Update
September 23 2009
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
McGill University
Montreal, Quebec, Canada, H3G 1A8
2
Montreal Children's Hospital
Montreal, Quebec, Canada, H3H 1P3